Senate Committee On Aging

Upcoming Hearing

The Doctor Is Out: How Washington’s Rules Drove Physicians Out of Medicine

February 11th, 2026 at 3:30PM

SH-216

View All Hearings

JOINT PRESS

Feb. 05

Chairman Scott, Ranking Member Gillibrand Introduce CLEAR LABELS Act to Protect American Patients Through Drug...

WASHINGTON, D.C. – Today, Chairman Rick Scott and Ranking Member Kirsten Gillibrand introduced the Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for...

Jan. 28

El presidente del Comité Rick Scott y la miembro de alto rango Kirsten Gillibrand liderarán la audiencia que...

WASHINGTON, D.C. – El Jueves, 29 de Enero, el presidente del Comité Rick Scott y la miembro de alto rango Kirsten Gillibrand del Comité Especial del Senado de EE.UU para asuntos de...

CHAIRMAN
Rick Scott (R-FL)

MAJORITY NEWS

Feb. 05

Chairman Scott, Ranking Member Gillibrand Introduce CLEAR LABELS Act to Protect American Patients Through Drug Origin Transparency and Stronger Supply Chain Oversight

Jan. 29

Chairman Rick Scott Calls for Transparency of Foreign-Made Generic Drugs, Announces CLEAR LABELS Act to Require Country-of-Origin Labeling

Jan. 29

El presidente del Comité Rick Scott pide transparencia en los medicamentos genéricos fabricados en el extranjero y anuncia que la Ley CLEAR LABELS exigirá el etiquetado por país de origen

RANKING MEMBER
Kirsten E. Gillibrand
(D-NY)

MINORITY NEWS

Feb. 05

Chairman Scott, Ranking Member Gillibrand Introduce CLEAR LABELS Act to Protect American Patients Through Drug Origin Transparency and Stronger Supply Chain Oversight

Jan. 28

El presidente del Comité Rick Scott y la miembro de alto rango Kirsten Gillibrand liderarán la audiencia que examina la transparencia y las propuestas de etiquetado por país de origen para medicamentos genéricos

Jan. 28

Chairman Rick Scott, Ranking Member Kirsten Gillibrand to Lead Hearing Examining Transparency and Country-of-Origin Labeling Proposals for Generic Drugs